CompletedNot Applicable

Balancing Risk: Red Blood Cell Transfusion Strategies In Cardiac Surgery

United States, India722 participantsStarted 2007-03

Plain-language summary

The primary purpose of this study is to determine the best blood level to begin transfusing red blood cells in individuals undergoing cardiac surgery. The secondary aim is to determine the impact of red cell transfusion on health-related quality of life following surgery.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * All primary and reoperative adult cardiac surgical patients undergoing cardiopulmonary bypass for coronary artery bypass grafting, coronary artery bypass grafting with a valve procedure, isolated valve procedures and ascending aortic repair for aneurysm or dissection procedures. Exclusion Criteria: * Age less than 18 years * Congenital procedures * Emergencies * descending thoracic aortic aneurysm repairs * Left or right ventricular assist devices * Left ventricular aneurysm resections * Heart or lung transplantation * Those unable to receive blood for religious reasons

What they're measuring

A Composite of In-hospital Postoperative Morbidity and Mortality

Timeframe: After surgery until hosptal discharge

Trial details

NCT IDNCT00651573

SponsorThe Cleveland Clinic

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2014-08

Results submitted2019-03-12

View on ClinicalTrials.gov More Anemia trials